Jiujiang Xiangmojin Trading Co Ltd, et al. v. Interlink Products International Inc, et al.

CourtDistrict Court, E.D. New York
DecidedOctober 21, 2025
Docket1:25-cv-06235
StatusUnknown

This text of Jiujiang Xiangmojin Trading Co Ltd, et al. v. Interlink Products International Inc, et al. (Jiujiang Xiangmojin Trading Co Ltd, et al. v. Interlink Products International Inc, et al.) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jiujiang Xiangmojin Trading Co Ltd, et al. v. Interlink Products International Inc, et al., (E.D.N.Y. 2025).

Opinion

1 2 3 4

5 6 7 UNITED STATES DISTRICT COURT 8 WESTERN DISTRICT OF WASHINGTON AT SEATTLE 9 10 JIUJIANG XIANGMOJIN TRADING CO CASE NO. 2:24-cv-02034-LK 11 LTD, et al., ORDER GRANTING 12 Plaintiffs, DEFENDANTS’ MOTION TO v. TRANSFER 13 INTERLINK PRODUCTS 14 INTERNATIONAL INC, et al., 15 Defendants. 16

This matter comes before the Court on Defendants’ Motion to Transfer or, in the 17 Alternative, to Dismiss for Lack of Personal Jurisdiction and Improper Venue. Dkt. No. 13. For 18 the reasons set forth below, the Court grants the motion to transfer and denies as moot the 19 alternative request to dismiss. 20 21 I. BACKGROUND Plaintiffs Jiujiang Xiangmojin Trading Co. Ltd., Dongguan Weihuanya Trading Co. Ltd., 22 Li Ling, Hui’an Mubing E-commerce Co. Ltd., Yongzhou Qianliren Technology Co. Ltd., Xiantao 23 Wensheng Technology Co. Ltd., Yongzhou Lengshuitan District Shanqu Trading Co. Ltd., and 24 1 Aqua Home Product Inc. are Amazon sellers who market and sell showerheads on Amazon and 2 on their independent websites. Dkt. No. 1 at 5. After Defendant Interlink Products International, 3 Inc. submitted an infringement complaint through Amazon’s Patent Evaluation Express Program 4 (“APEX Program”)1 in November 2024, Plaintiffs sued Interlink and Eli Zhadanov, the inventor

5 of the allegedly infringed patent—U.S. Patent No. 11,992,850 (“the ’850 Patent”)—for declaratory 6 judgment that the products listed in Interlink’s infringement complaint do not infringe the ’850 7 Patent. Id. at 2, 5, 9–15.2 8 On July 11, 2025, Defendants moved to transfer this action to the United States District 9 Court for the Eastern District of New York or, in the alternative, to dismiss the complaint for lack 10 of personal jurisdiction and/or improper venue. See Dkt. No. 13 at 2. 11 II. DISCUSSION 12 A. Legal Standard 13 For the convenience of parties and witnesses, and in the interest of justice, a district court 14 has discretion to “transfer any civil action to any other district or division where it might have been

15 brought[.]” 28 U.S.C. § 1404(a). “Venue in a declaratory judgment action for patent 16 1 The APEX Program is a dispute resolution mechanism whereby patent owners and Amazon sellers can agree to a 17 neutral third-party evaluation of whether accused products likely infringe utility patents. See Dkt. No. 14 at 3–4; Dkt. No. 2 at 40–44. To initiate dispute resolution under the APEX Program, a patent owner or authorized representative 18 thereof executes Amazon’s Patent Evaluation Express Agreement (“APEX Agreement”), including an exhibit describing the allegedly infringing products, and submits it to Amazon. Dkt. No. 2 at 25, 40. Once signed by the party alleging infringement, Amazon forwards the APEX Agreement to the seller of the accused products. The seller then 19 has the option of accepting the dispute resolution offer by executing the APEX Agreement, declining to participate, or doing nothing. Id. at 28. If both the complainant and seller execute the APEX Agreement, they are the only parties 20 thereto; they waive any claims against Amazon or the evaluator. Id. at 24. Each side pays $4,000 for the evaluation. Id. at 40. If the evaluator finds that the complainant “is likely to prove that all Accused Products infringe” the asserted claim, the complainant’s $4,000 fee will be refunded, and Amazon will remove the accused product from its platform. 21 Id. at 43. If the evaluator finds that the complainant “is not likely to prove that any Accused Product infringes” the asserted claim, the seller’s $4,000 fee will be refunded, and its products will remain on Amazon. Id. “There is no 22 process for reconsideration of the Evaluator’s decision, though either side may appeal to Amazon by providing a court order that conflicts with the Evaluator’s decision concerning invalidity or infringement.” Id. at 42–43. If the seller 23 declines to participate in the APEX Program or does nothing, Amazon will remove the accused products from its platform unless the seller files an action for declaratory judgment of non-infringement of the asserted patent in court, in which case Amazon will permit the items to remain on its platform “while the lawsuit proceeds.” Id. at 28, 40. 24 2 Interlink is the exclusive, albeit limited, licensee of the ’850 Patent. Dkt. No. 15 at 2. 1 noninfringement and invalidity is governed by the general venue statute, 28 U.S.C. § 1391(b) and 2 (c), and not the special patent infringement venue statute, 28 U.S.C. § 1400(b).” U.S. Aluminum 3 Corp. v. Kawneer Co., 694 F.2d 193, 195 (9th Cir. 1982). 4 District courts typically weigh the following factors when determining whether transfer is

5 appropriate under Section 1404(a): 6 (1) [T]he location where the relevant agreements were negotiated and executed, (2) the state that is most familiar with the governing law, (3) the plaintiff’s choice 7 of forum, (4) the respective parties’ contacts with the forum, (5) the contacts relating to the plaintiff’s cause of action in the chosen forum, (6) the differences in 8 the costs of litigation in the two forums, (7) the availability of compulsory process to compel attendance of unwilling non-party witnesses . . . (8) the ease of access to 9 sources of proof[, and (9)] the relevant public policy of the forum state[.]

10 Jones v. GNC Franchising, Inc., 211 F.3d 495, 498–99 (9th Cir. 2000). “The party moving for 11 transfer of a case bears the burden of demonstrating transfer is appropriate.” Cirafici v. City of 12 Ithaca, 968 F.2d 1220 (9th Cir. 1992). A court does not need to have personal jurisdiction over a 13 defendant in order to reach the merits of its motion to transfer. Goldlawr, Inc. v. Heiman, 369 U.S. 14 463, 466 (1962). 15 B. The Relevant Factors Favor Transfer Here 16 1. Location where the relevant agreements were negotiated and executed 17 Defendants argue that this factor is inapplicable. Dkt. No. 13 at 8. Plaintiffs contend that 18 their claims “arise directly out of Defendants’ execution and submission of [the APEX] agreement, 19 which might trigger the removal of Plaintiffs’ product listings[.]” Dkt. No. 19 at 9. In addition, 20 Plaintiffs argue that “Defendants’ agreement to litigate matters arising from the APEX Program in 21 King County supports keeping the case in this District[.]” Id. at 10. Plaintiffs point to Section 5 of 22 the Agreement, which states that “Participants”—defined as the patent owner or authorized 23 representative thereof and the seller—“agree[] to the jurisdiction and venue of the federal and state 24 courts located in King County, Seattle, Washington.” Dkt. No. 2 at 24. 1 Although Plaintiffs argue that their decision not to sign the APEX agreement is immaterial, 2 Dkt. No. 19 at 9, it is black letter law that “for a contract to form, the parties must objectively 3 manifest their mutual assent.” Keystone Land & Dev. Co. v. Xerox Corp., 94 P.3d 945, 949 (Wash. 4 2004). No Plaintiff signed the agreement, nor did Zhadanov.3 That Interlink was willing to litigate

5 disputes arising from the APEX Agreement in King County if Plaintiffs agreed to its alternative 6 dispute resolution offer does not make the APEX Agreement relevant here. As Defendants point 7 out, Dkt. No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Richards v. United States
369 U.S. 1 (Supreme Court, 1962)
Dudnikov v. Chalk & Vermilion Fine Arts, Inc.
514 F.3d 1063 (Tenth Circuit, 2008)
In Re Genentech, Inc.
566 F.3d 1338 (Federal Circuit, 2009)
Inre: Toa Technologies, Inc.
543 F. App'x 1006 (Federal Circuit, 2013)
In Re Hoffmann-La Roche Inc.
587 F.3d 1333 (Federal Circuit, 2009)
Doe v. Geller
533 F. Supp. 2d 996 (N.D. California, 2008)
Celgard, LLC v. Sk Innovation Co., Ltd.
792 F.3d 1373 (Federal Circuit, 2015)
Xilinx, Inc. v. Papst Licensing Gmbh & Co. Kg
848 F.3d 1346 (Federal Circuit, 2017)
Jones v. GNC Franchising, Inc.
211 F.3d 495 (Ninth Circuit, 2000)
Rollins v. Dignity Health
19 F. Supp. 3d 909 (N.D. California, 2013)
Licci v. Lebanese Canadian Bank SAL
732 F.3d 161 (Second Circuit, 2013)
Jetblue Airways Corp. v. Helferich Patent Licensing, LLC
960 F. Supp. 2d 383 (E.D. New York, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Jiujiang Xiangmojin Trading Co Ltd, et al. v. Interlink Products International Inc, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/jiujiang-xiangmojin-trading-co-ltd-et-al-v-interlink-products-nyed-2025.